CDKN2A and melanoma: In good agreement, Longo et al. [88] showed that early melanomas in CDKN2A mutation carriers with RHC variants are more difficult to diagnose, even when employing a comparative approach aimed to evaluate the single lesion in the context of the patient’s overall nevus profile.